TP53INP2 Polyclonal Antibody

货号：ES6958
价格：面议
点击：2140

产品介绍

抗体信息

应用	IHC-p;IF/ICC;ELISA
反应种属	Human;Mouse;Rat
别称	TP53INP2; C20orf110; DOR; PINH; Tumor protein p53-inducible nuclear protein 2; Diabetes and obesity-regulated gene; p53-inducible protein U; PIG-U

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Isatuximab Non-Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗非中和重组抗体(靶标：艾沙妥昔单抗非中和抗体)	309
Anti-Isatuximab Non-Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗非中和重组抗体(靶标：艾沙妥昔单抗非中和抗体)	550
Anti-Isatuximab Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗中和重组抗体(靶标：艾沙妥昔单抗中和抗体)	433
Anti-Isatuximab Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗中和重组抗体(靶标：艾沙妥昔单抗中和抗体)	276
Anti-Isatuximab Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗中和重组抗体(靶标：艾沙妥昔单抗中和抗体)	233
Anti-Urelumab Non-Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗非中和重组抗体(靶标：乌瑞鲁单抗非中和抗体)	507
Anti-Urelumab Non-Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗非中和重组抗体(靶标：乌瑞鲁单抗非中和抗体)	534
Anti-Urelumab Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗中和重组抗体(靶标：乌瑞鲁单抗中和抗体)	542
Anti-Urelumab Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗中和重组抗体(靶标：乌瑞鲁单抗中和抗体)	544
Anti-Urelumab Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗中和重组抗体(靶标：乌瑞鲁单抗中和抗体)	486
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	267
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	377
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	583
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	251
Anti-Ranibizumab Non-Neutralizing Recombinant Antibody \|抗雷珠单抗非中和重组抗体(靶标：雷珠单抗非中和抗体)	480
Anti-Ranibizumab Non-Neutralizing Recombinant Antibody \|抗雷珠单抗非中和重组抗体(靶标：雷珠单抗非中和抗体)	356
Anti-Ranibizumab Non-Neutralizing Recombinant Antibody \|抗雷珠单抗非中和重组抗体(靶标：雷珠单抗非中和抗体)	469
Anti-Ranibizumab Neutralizing Recombinant Antibody \|抗雷珠单抗中和重组抗体(靶标：雷珠单抗中和抗体)	341
Anti-Ranibizumab Neutralizing Recombinant Antibody \|抗雷珠单抗中和重组抗体(靶标：雷珠单抗中和抗体)	464
Anti-Ranibizumab Neutralizing Recombinant Antibody \|抗雷珠单抗中和重组抗体(靶标：雷珠单抗中和抗体)	252

在线客服

QQ交谈

销售热线：
15898894496(同微信)
我要留言
周一至周五每天9:00-17:00